BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2026 9:35:00 AM | Browse: 2 | Download: 0
 |
Received |
|
2026-03-20 13:30 |
|
Peer-Review Started |
|
2026-03-20 13:32 |
|
First Decision by Editorial Office Director |
|
2026-05-08 10:05 |
|
Return for Revision |
|
2026-05-08 10:05 |
|
Revised |
|
2026-06-02 12:21 |
|
Publication Fee Transferred |
|
2026-06-08 05:55 |
|
Second Decision by Editor |
|
2026-06-22 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-22 06:51 |
|
Articles in Press |
|
2026-06-22 06:51 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-29 08:42 |
|
Publish the Manuscript Online |
|
2026-07-14 09:35 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Diagnostic efficacy of fecal calprotectin combined with a high-sensitivity quantitative fecal immunochemical test for colorectal tumors
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Jing, Lei Qin, Xiao-Han Zhang, Fei Pan, Rong-Rong Ren, Yan Li, Yan Zhang, Li-Hua Peng, Zi-Kai Wang and Xiu-Li Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiu-Li Zhang, Chief, MD, PhD, Microbiota Division, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. zhangxl70@126.com |
| Key Words |
Colorectal tumors; Colorectal cancer; Advanced adenoma; Fecal immunochemical test; Fecal calprotectin; Diagnostic efficiency |
| Core Tip |
Fecal calprotectin is a calcium-containing antimicrobial protein complex. Currently, it is primarily used in clinical practice for the diagnosis and monitoring of inflammatory bowel disease; however, its diagnostic value in colorectal tumors remains to be established. This paper draws a preliminary conclusion that fecal calprotectin can serve as a reliable biomarker for colorectal cancer. When combined with the fecal high-sensitivity quantitative immunochemical test, calprotectin increases the sensitivity for diagnosing colorectal cancer to 87.5%, raises the negative predictive value to 82.8%, and achieves an area under the receiver operating characteristic curve of 0.866. The combination of two biomarkers enhances the diagnostic efficacy for colorectal tumors. |
| Publish Date |
2026-07-14 09:35 |
| Citation |
Jing W, Qin L, Zhang XH, Pan F, Ren RR, Li Y, Zhang Y, Peng LH, Wang ZK, Zhang XL. Diagnostic efficacy of fecal calprotectin combined with a high-sensitivity quantitative fecal immunochemical test for colorectal tumors. World J Gastroenterol 2026; 32(28): 121267
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i28/121267.htm |
| DOI |
https://doi.org/10.3748/wjg.121267 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
